To include your compound in the COVID-19 Resource Center, submit it here.

Everolimus regulatory update

Novartis amended an sNDA for everolimus and is now seeking approval for treatment of advanced

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE